-
NS1–DNMT1 Control of HBoV1 RNA Processing
2026-08-23
A 2024 PLOS Pathogens study identifies a regulatory link between HBoV1 NS1, host DNMT1 degradation, viral DNA methylation, genome replication, and RNA maturation. The findings support a model in which DNMT1 promotes viral DNA synthesis, whereas NS1-driven DNMT1 removal favors RNA processing and viral protein expression.
-
DiscoveryProbe Protease Inhibitor Library Workflow
2026-08-22
Build phenotype-first and enzyme-based screens with 825 pre-dissolved protease inhibitors spanning diverse inhibitor classes. A plant stomatal-opening study illustrates how inhibitor panels can move beyond hit finding to pathway localization, while practical controls help separate protease inhibition from cytotoxicity, fluorescence artifacts, and general signaling disruption.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-08-22
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve the apparent aqueous solubility of poorly soluble hydrophobic compounds, particularly molecules with aromatic or phenyl groups. This guide supports pharmaceutical and biochemical formulation workflows, but solubility improvement alone does not establish bioavailability, efficacy, safety, or suitability outside those settings.
-
Rucaparib (AG-014699) DNA Repair Workflows
2026-08-21
Rucaparib (AG-014699) enables controlled studies of PARP1 inhibition, persistent DNA breaks, and radiation response across repair-deficient cancer models. This practical guide connects radiosensitization of prostate cancer cells with emerging SmD2–BRCA1/FANC splicing biology in hepatocellular carcinoma.
-
PXDN–LDHA: Smarter Gene Delivery in GBM
2026-08-20
The PXDN–LDHA axis offers a compelling framework for studying glycolytic progression in glioblastoma. This thought-leadership article shows how careful nucleic acid delivery, low-toxicity workflows, and rescue experiments can convert a mechanistic observation into a more reproducible translational research program.
-
TNFα, Vasorin, and Glioma Stem Cell Self-Renewal
2026-08-20
This study identifies a dose-dependent paradox in glioma biology: low tumor necrosis factor α supports glioma stem cell self-renewal rather than suppressing it. The authors connect this effect to Vasorin-driven glycolysis and a lactate-mediated feedback loop involving tumor-associated macrophages, providing a mechanistic framework for interpreting TNFα resistance in glioblastoma.
-
Biotin-tyramide for TSA and Senescence Imaging
2026-08-19
Biotin-tyramide enables localized signal amplification for low-abundance RNA and protein targets in fixed cells and tissue. This practical guide connects TSA workflow design with the PURPL–H3K9me3 senescence model, while emphasizing controls, multiplexing, and troubleshooting.
-
Lysobacter Rewires DSF Signaling for Antifungal Defense
2026-08-19
This study shows that Lysobacter enzymogenes uses the DSF quorum-sensing component RpfG to regulate heat-stable antifungal factor production through a mechanism that is independent of RpfG phosphodiesterase activity. Its central innovation is the identification of three hybrid two-component proteins that connect RpfG interaction, phosphorylation-dependent regulation, and promoter control of antifungal biosynthesis.
-
X-ray Cherenkov Activation of Caged Doxorubicin
2026-08-18
Yao and colleagues developed folate-decorated nano-micelles that use X-ray-induced Cherenkov light to uncage doxorubicin and promote its redistribution into tumor-cell nuclei. The study combines receptor-directed uptake, localized radiation activation, and nuclear drug delivery to improve chemoradiation efficacy while reducing systemic exposure.
-
Topotecan: Topoisomerase I Inhibition in Oncology
2026-08-18
The 1999 review by Kollmannsberger and colleagues examined how topotecan converts topoisomerase I activity into a selective DNA-damage mechanism through stabilization of the cleavable complex. Its pharmacokinetic profile, hematologic toxicity, and activity in ovarian and small-cell lung cancers established a foundation for evaluating schedule, renal dosing, and combination strategies.
-
Phosbind Biotin for Protein Phosphorylation
2026-08-17
Phosbind Biotin provides a sequence-independent route to phosphorylated protein detection on PVDF, reducing dependence on site-specific antibody availability. This practical guide connects the reagent to PtrbZIP12 drought-response research, with workflow controls, optimization parameters, and troubleshooting strategies for reproducible protein phosphorylation analysis.
-
KN-62 for Reliable CaMKII Assays
2026-08-17
A scenario-based guide to using KN-62 in calcium-signaling, viability, proliferation, and cytotoxicity workflows. It explains how SKU A8180 supports controlled CaMKII perturbation while addressing solvent compatibility, dose design, interpretation, and supplier selection.
-
Radiotherapy, PD-1 and TIGIT Drive Abscopal Immunity
2026-08-16
This 2025 Cancer Letters study shows that radiotherapy combined with PD-1 and TIGIT blockade can control both irradiated and distant tumors in several syngeneic mouse models. Its main mechanistic contribution is identifying activated, less-exhausted CD8+ T cells and M1 macrophage cooperation as drivers of abscopal tumor control and durable immune memory.
-
Angiotensin II Workflows for Vascular Aging
2026-08-15
Build reproducible Angiotensin II models for endothelial senescence, oxidative stress, vascular remodeling, and aneurysm biology. This practical guide connects receptor-proximal stimulation with MFN2-focused mitochondrial assays and provides dose, storage, controls, and troubleshooting guidance.
-
Spermine Tetrahydrochloride for Translation
2026-08-14
Spermine tetrahydrochloride is more than a polyamine reagent: its charge-driven behavior can be used as a controllable design variable for protoplast protection, protein crystallization, and ionic polyphosphazene formulations. This evidence-led perspective connects molecular mechanism with translational workflow decisions while defining where neuroscience claims still require independent validation.